In our specific corner of the world at Flourish, we care sincerely about the well-being of our clients. We hope for our practice to be a true safe place for women and issues related to diversity and varied cultural considerations play a huge role in...
On August 6 th , the Food and Drug Administration (FDA) approved the first oral medication for the treatment of postpartum depression. The last time we had a medication approved for postpartum depression was in 2019 when the FDA approved brexanolone. While many were very...
For many of us, the link between mental wellbeing and our reproductive health is something that is not really talked about. Decisions about our reproductive health can be complicated, exciting, and confusing - especially because they also have long-term implications. In order to make those...
We cannot underestimate the importance of increasing awareness of perinatal mood disorders and erasing the stigma associated with mental health struggles. In recent years we have seen a cultural shift towards women being more transparent about their fertility and motherhood journeys including perinatal mood and...